Filing Details

Accession Number:
0000874716-23-000041
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-08 17:01:45
Reporting Period:
2023-05-05
Accepted Time:
2023-05-08 17:01:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740689 Michael Lane One Idexx Drive
Westbrook ME 04092
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-05 1,000 $484.00 4,022 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 592 Indirect by spouse
Footnotes
  1. Includes 14.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023.
  2. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.